Replies to post #621 on Acadia Pharmaceuticals Inc. (ACAD)

[Jumpinjackas]

They usually are very conservative with targets before data. So, I'm sure there will be upgrades post data.

Besides, we know from last time how far it can run up. This time, it will continue post data.

[Calikush420]

Why don't they put a new target since we already hit that one??? What a crappy analyst I bet in November this will be $5-6 on the run up to phase 3 then $10 after aproval simalar to ARNA I think the run up should be better than the last trail and less of a pop after aproval since this ones got a 80% chance this time anyways I think it's time to change that old target and set a new one of $6.00